Argenx Beats Sales Expectations — But Not By Enough — And Shares Tumble

Argenx banal tumbled Thursday aft its drug, Vyvgart, bushed income expectations. But the bushed wasn't beardown capable for investors.
The station Argenx Beats Sales Expectations — But Not By Enough — And Shares Tumble appeared archetypal connected Investor's Business Daily.

This communicative appeared connected investors.com, 2025-05-08 12:55:08.